Table 3.
Adverse events through Week 52 (n = 5).
| Event term | CTCAE grade | Seriousness (ICH E2A) | Relatedness | Onset date | Resolution date | Action taken |
|---|---|---|---|---|---|---|
| None observed | None observed | None observed | None observed | None observed | None observed | None observed |
Events are coded and graded according to CTCAE v5.0; seriousness is defined per ICH E2A. Relationship to study treatment was assessed by the investigator. No treatment-related AEs or SAEs were observed, and no immediate intra-articular flares (swelling/pain), infections, hemarthrosis, or hospitalizations occurred. Counts reflect observed cases only (no imputation). AE, adverse event; SAE, serious adverse event; CTCAE, Common Terminology Criteria for Adverse Events; ICH, International Council for Harmonisation.